Search

Your search keyword '"A. Viros"' showing total 59 results

Search Constraints

Start Over You searched for: Author "A. Viros" Remove constraint Author: "A. Viros" Topic business.industry Remove constraint Topic: business.industry
59 results on '"A. Viros"'

Search Results

1. Molecular characterization of fast-growing melanomas

2. Association between age at disease onset of anti-neutrophil cytoplasmic antibody-associated vasculitis and clinical presentation and short-term outcomes

3. The paradox-breaking panRAF plus SRC family kinase inhibitor, CCT3833, is effective in mutant KRAS-driven cancers

4. Effectiveness of telemedicine in patients with heart failure according to frailty phenotypes: insights from the iCOR randomised controlled trial

5. Frailty phenotypes in patients with heart failure in the early post-discharge period: insights from the iCOR randomised controlled trial and a machine learning-based clustering analysis

6. Daphne: A Virtual Assistant for Designing Earth Observation Distributed Spacecraft Missions

7. Positive Attributes of Anti-TERT CD4 T-Helper Type 1 Immune Responses in Melanoma

8. Experimental Design & Pilot Testing for ECLSS Anomaly Resolution using Daphne-AT Virtual Assistant

9. Distribution and clinical role of KIT gene mutations in melanoma according to subtype: a study of 492 Spanish patients

10. Female immunity protects from cutaneous squamous cell carcinoma

11. MOLECULAR LANDSCAPE OF OLD AGE MELANOMA BY SURVIVAL AND IMMUNOTHERAPY RESPONSE

12. Brain microenvironment-driven resistance to immune and targeted therapies in acral melanoma

13. Polypharmacy in older people: lessons from 10 years of experience with the REPOSI register

14. Prognostic relevance of glomerular filtration rate estimation obtained through different equations in hospitalized elderly patients

15. Ultraviolet light and melanoma

16. New biomarkers improve stratification of patients with melanoma

17. Transoral robotic surgery for squamous cell carcinoma of the oropharynx in a primarily human papillomavirus-negative patient population

18. Histologic Features Associated With an Invasive Component in Lentigo Maligna Lesions

19. Nodular Melanoma: A Histopathologic Entity?

20. 940P Analysis of a cohort of elderly patients (p) with head and neck cancer (HNC) managed within a multidisciplinary head and neck cancer unit (HNCU)

21. Correction: Cutaneous melanoma primary site is linked to nevus density

22. Application of Sequencing, Liquid Biopsies, and Patient-Derived Xenografts for Personalized Medicine in Melanoma

23. Prevalence, characteristics and treatment of chronic pain in elderly patients hospitalized in internal medicine wards

24. Implementation of the Frailty Index in hospitalized older patients: Results from the REPOSI register

25. Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study

26. Risk factors for three-month mortality after discharge in a cohort of non-oncologic hospitalized elderly patients: Results from the REPOSI study

27. Cutaneous melanoma primary site is linked to nevus density

28. Abstract 3994: Genomic characterization of melanoma in the elderly reveals molecular drivers of progression and prognosis associated with immunotherapy response

29. Abstract 2022: Chronic UV damage of the stroma improves melanoma survival

30. Defining aging phenotypes and related outcomes: Clues to recognize frailty in hospitalized older patients

31. Mechanisms of Drug Resistance in Melanoma

32. Pattern of in-hospital changes in drug use in the older people from 2010 to 2016

33. Use of non-steroidal anti-inflammatory drugs and analgesics in a cohort of hospitalized elderly patients: Results from the REPOSI study

34. RASMutations in Cutaneous Squamous-Cell Carcinomas in Patients Treated with BRAF Inhibitors

35. Publisher Correction: Ultraviolet radiation–induced DNA damage is prognostic for outcome in melanoma

36. Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study

37. Keratosis lichenoides chronica masquerading as discoid lupus erythematosus

38. Síndrome esclerodermiforme por paclitaxel

39. Abstract 3704: Novel panRAF inhibitors active in melanomas that are resistant to BRAF-selective, or BRAF-selective/MEK inhibitor combinations

40. Abstract 2400: Mechanisms of resistance to immuno and targeted therapies in acral melanoma

41. Abstract 470: Application of sequencing, liquid biopsies and patient derived xenografts for personalized medicine in melanoma

42. Abstract LB-212: Therapeutic efficacy of the paradox-breaking panRAF and SRC drug CCT3833/BAL3833 in KRAS-driven cancer models

43. Abstract 3207: Influence of tumor mutation burden on response to anti-PD-1 treatment in murine models of melanoma

45. Therapeutic efficacy of the paradox-breaking panRAF and SRC drug CCT3833/BAL3833 in KRAS-driven cancer models

46. Impact of molecular prescreening for genomically-guided trials in head and neck cancer (HNC)

47. Analysis of the efficacy and toxicity of sorafenib in thyroid cancer: a phase II study in a UK based population

48. Hooked on UVR

49. Abstract 2683: Simultaneous inactivation of TP53 and loss of PTEN diminish response to targeted therapy in V600EBRAF mutant melanoma

50. Abstract 5024: Implications of MAPK pathway inhibition on monocytes and tumor-associated macrophages in melanoma

Catalog

Books, media, physical & digital resources